CircRNA: An emerging star in the progression of glioma

Dazhao Peng1, Lin Luo2, Xiaoyang Zhang1

  • 1Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Neuro-repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin Medical University General Hospital, Tianjin 300052, China.

Insights

Circular RNAs (circRNAs) are stable molecules implicated in diseases like cancer. This review explores circRNA functions, biogenesis, and their role in glioma progression.

Area of Science:

  • Molecular Biology
  • Genomics
  • Neuroscience

Background:

  • Circular RNAs (circRNAs) are noncoding RNAs with a unique closed-loop structure.
  • They are stable, abundant, conserved, and exhibit tissue-specific expression patterns.
  • circRNAs are increasingly recognized as potential biomarkers and therapeutic targets for various diseases, including cancers and neurological disorders.

Purpose of the Study:

  • To review the classification, biogenesis mechanisms, and biological functions of circRNAs.
  • To discuss the abnormal expression of circRNAs in disease contexts.
  • To highlight the role of circRNAs in glioma and explore research methodologies.

Main Methods:

  • Literature review and synthesis of existing research on circRNAs.
  • Bioinformatic analysis and deep sequencing data interpretation.
  • Exploration of molecular mechanisms underlying circRNA regulation and function.

Main Results:

  • circRNAs are frequently found in brain tissues and show dynamic expression during neural development.
  • Abnormal circRNA expression is linked to the development and progression of neurological diseases like glioma.
  • circRNAs influence the malignant biological capabilities of glioma cells.

Conclusions:

  • circRNAs play significant roles in the nervous system, particularly in glioma pathogenesis.
  • Further research into circRNA biogenesis and function is crucial for developing novel diagnostic and therapeutic strategies.
  • Understanding circRNA mechanisms is essential for targeting diseases like glioma effectively.